A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
BACKGROUND: Familial hypercholesterolaemia (FH) affects approximately 1 in 500 people (10 million world-wide) and the elevated serum cholesterol concentrations lead to a more than 50% risk of fatal or non-fatal coronary heart disease by age 50 years in men and at least 30% in women aged 60 years. B...
Main Authors: | Marks, D, Thorogood, M, Neil, H, Humphries, SE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2003
|
Similar Items
-
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, D, et al.
Published: (2000) -
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, et al.
Published: (2000-01-01) -
Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
by: Marks, D, et al.
Published: (2006) -
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
by: Marks, D, et al.
Published: (2002) -
Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
by: Marks, D, et al.
Published: (2003)